Phase 1 Immunization Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years

Chlamydia Trachomatis Immunization

Sanofi1,560 enrolled7 locationsNCT06891417

Recruiting

Phase 1Phase 2

Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination

Yellow FeverImmunization; Infection

Oregon Health and Science University35 enrolled1 locationNCT05859490